ZePing Zhou: Clinical Trials

2 trials sponsored by ZePing Zhou, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Unknown 2
Phase 22Unknown 2

Follow ZePing Zhou: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML.
combination of venetoclax and HAA regimen - Acute Myeloid Leukemia, Venetoclax
Phase 1 / Phase 2UnknownZePing Zhou452023-04-012023-06-08
Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly
Venetoclax in Combination With Azacitidine and HA Regimen - Acute Myeloid Leukemia
Phase 1 / Phase 2UnknownZePing Zhou452023-04-012023-07-18

Conditions studied

Leukemia, Myeloid, Acute (2)

Interventions

Azacitidine (1)  ·  venetoclax (1)

Countries

China (2)

Top investigators

DanQi Deng (1)